Skip to main content
Cassie Pan, MD

Cassie Pan, MD

ASSISTANT PROFESSOR

Biography

Cassie Pan, MD, is an assistant professor in the Department of Otolaryngology–Head and Neck Surgery at the University of Washington. She specializes in head and neck surgical oncology and microvascular reconstruction. Her clinical practice encompasses benign and malignant tumors of the head and neck, including mucosal tumors, thyroid and salivary gland tumors, and skin cancers.

Dr. Pan completed her medical degree at Yale School of Medicine and her residency in otolaryngology–head and neck surgery at the University of Washington, including a T32 research year. She subsequently completed fellowship training in head and neck oncologic surgery and microvascular reconstruction at Vanderbilt University Medical Center.

Her research focuses on identifying biomarkers to guide treatment decisions and improve outcomes for patients with head and neck cancer, with particular interests in immunotherapy outcomes and translational clinical trials. She is also committed to resident education and mentoring future surgeons.

Current CV

Cassie Pan CV 2026.10.05.pdf

Overview

Undergraduate Education: BS in Chemistry, Yale University

Medical School: Yale School of Medicine

Residency: Residency: Otolaryngology - Head and Neck Surgery, University of Washington, Seattle, WA

Fellowship: Head and Neck Surgical Oncology and Microvascular Reconstruction, Vanderbilt University Medical Center, Nashville, TN

Memberships: American Head and Neck Society, American Academy of Otolaryngology-Head and Neck Surgery, American Rhinologic Society

Recent Publications

Research Focus

Dr. Pan's research focuses on biomarkers of treatment response and outcomes in head and neck cancer, particularly in patients receiving immunotherapy, as well as the development and conduct of translational clinical trials. She has led an investigator-initiated clinical trial evaluating fluorescent imaging to improve intraoperative tumor visualization and surgical margin assessment. Through collaborations across the University of Washington, Fred Hutch Cancer Center, and the VA Puget Sound Health Care System, she hopes to advance personalized treatment strategies and improve cancer care for diverse patient populations.